Pine River Capital Management L.P. - AVALANCHE BIOTECHNOLOGIES IN ownership

Back to all holdings Add to watchlist

AVALANCHE BIOTECHNOLOGIES IN's ticker is AAVL and the CUSIP is 05337G107. A total of 94 filers reported holding AVALANCHE BIOTECHNOLOGIES IN in Q3 2015. The put-call ratio across all filers is 2.32 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Pine River Capital Management L.P. ownership history of AVALANCHE BIOTECHNOLOGIES IN
ValueSharesWeighting
Q2 2015$421,000
-59.9%
25,8940.0%0.01%
-61.5%
Q1 2015$1,050,000
-24.9%
25,8940.0%0.01%
-27.8%
Q4 2014$1,398,000
-21.1%
25,894
-50.0%
0.02%
-14.3%
Q3 2014$1,771,000–51,790–0.02%–
 Download
Other shareholders

There were no reported owners of AVALANCHE BIOTECHNOLOGIES IN in Q3 2015.

NameSharesValueWeighting ↓
View complete list of AVALANCHE BIOTECHNOLOGIES IN shareholders